Cytek Biosciences (CTKB) Net Income towards Common Stockholders (QoQ) (2020 - 2026)
Cytek Biosciences (CTKB) Net Income towards Common Stockholders (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn |
| 10 | Cytek Biosciences | 609.11 Mn | 535.27 Mn | 28.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 35.56% |
| Mar 31, 2026 | 57.20% |
| Dec 31, 2025 | -704.60% |
| Sep 30, 2025 | 1.88% |
| Jun 30, 2025 | 51.03% |
| Mar 31, 2025 | -218.24% |
| Dec 31, 2024 | 924.76% |
| Sep 30, 2024 | 109.02% |
| Jun 30, 2024 | -69.14% |
| Mar 31, 2024 | -212.10% |
| Dec 31, 2023 | 185.24% |
| Sep 30, 2023 | -47.13% |
| Jun 30, 2023 | 35.54% |
| Mar 31, 2023 | -292.89% |
| Dec 31, 2022 | 111.82% |
| Sep 30, 2022 | 378.60% |
| Jun 30, 2022 | 70.41% |
| Mar 31, 2021 | -82.26% |
| Dec 31, 2020 | -60.24% |
| Sep 30, 2020 | -23.89% |